Retour

Where Regenxbio Stands With Analysts

Analyst Analyst Ratings

Analysts' ratings for Regenxbio (NASDAQ:RGNX) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 4 2 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 4 2 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $38.22, a high estimate of $55.00, and a low estimate of $21.00. This current average has increased by 1.25% from the previous average price target of $37.75. Deciphering Analyst Ratings: An In-Depth Analysis In examining recent analyst actions, we gain insights into how financial experts perceive Regenxbio. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Annabel Samimy Stifel Maintains Buy $40.00 - Yi Chen HC Wainwright & Co. Announces Buy $36.00 - Luca Issi RBC Capital Raises Outperform $35.00 $20.00 Daniil Gataulin Chardan Capital Maintains Buy $52.00 $52.00 Gena Wang Barclays Raises Overweight $55.00 $45.00 Brian Skorney Baird Raises Outperform $39.00 $34.00 Andreas Argyrides Wedbush Maintains Neutral $21.00 - Dane Leone Raymond James Announces Outperform $45.00 - Andreas Argyrides Wedbush Maintains Neutral $21.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects ...Full story available on Benzinga.com

Benzinga • 12/04/2024 à 18:01:22
REGENXBIO Inc.
Address: 9804 MEDICAL CENTER DRIVE
Postal Code: 20850
City: ROCKVILLE
State: MD
Phone Number: 240-552-8181
Website: https://www.regenxbio.com
Status: Active
Company Info

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

List Date2015-09-17
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001590877
Composite figiBBG007Z9V591
Share Class figiBBG007Z9V5C7
Market Cap760,512,115 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees344
Share Class Shares Outstanding49260000
Weighted Shares Outstanding49255966
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
16.359
15.805
15.495
15.36
15.705
Variance
0.31%
1.23%
0.88%
-2.64%
-5.7%
Open
16.308
15.613
15.36
15.777
16.655
Highest
18.85
16.205
16.275
16.14
16.655
Lowest
18.85
16.205
16.275
16.14
16.655
History
PeriodVarhighestlowest
1 week
-3.96%
16.655
16.14
1 month
-17%
19.424
16.03
3 month
-12.88%
20.34
16.03
6 month
-16.3%
19.24
11.83
1 year
-24.94%
21.67
11.83
3 year
-55.32%
36.47
11.83
5 year
-65.04%
47.06
11.83
10 year
-47.14%
32
7.0701
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-08 UNPUB
Assets 747,830,000 682,458,000 633,786,000 UNPUB
Current Assets 389,202,000 378,809,000 365,838,000 UNPUB
Current Liabilities 112,334,000 117,893,000 127,346,000 UNPUB
Equity 465,139,000 405,855,000 363,100,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 465,139,000 405,855,000 363,100,000 UNPUB
Liabilities 282,691,000 276,603,000 270,686,000 UNPUB
Liabilities And Equity 747,830,000 682,458,000 633,786,000 UNPUB
Noncurrent Assets 358,628,000 303,649,000 267,948,000 UNPUB
Noncurrent Liabilities 170,357,000 158,710,000 143,340,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-08 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -26,861,000 -1,266,000 -15,555,000 UNPUB
Net Cash Flow, Continuing -26,861,000 -1,266,000 -15,555,000 UNPUB
Net Cash Flow From Financing Activities -9,037,000 -9,162,000 -4,805,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -9,037,000 -9,162,000 -4,805,000 UNPUB
Net Cash Flow From Investing Activities 63,094,000 55,218,000 38,657,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 63,094,000 55,218,000 38,657,000 UNPUB
Net Cash Flow From Operating Activities -80,918,000 -47,322,000 -49,407,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -80,918,000 -47,322,000 -49,407,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-08 UNPUB
Comprehensive Income/Loss -62,897,000 -70,537,000 -59,183,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -62,897,000 -70,537,000 -59,183,000 UNPUB
Other Comprehensive Income/Loss 3,779,000 1,524,000 2,685,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-03 2023-08-02 2023-11-08 UNPUB
Basic Earnings Per Share -2 -2 -1 UNPUB
Benefits Costs and Expenses 85,814,000 92,038,000 90,782,000 UNPUB
Cost Of Revenue 4,112,000 9,475,000 12,388,000 UNPUB
Costs And Expenses 85,295,000 93,085,000 93,874,000 UNPUB
Diluted Earnings Per Share -2 -2 -1 UNPUB
Gross Profit 15,026,000 10,502,000 16,526,000 UNPUB
Income/Loss From Continuing Operations After Tax -66,676,000 -72,061,000 -61,868,000 UNPUB
Income/Loss From Continuing Operations Before Tax -66,676,000 -72,061,000 -61,868,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 2,755,000 1,120,000 1,624,000 UNPUB
Net Income/Loss -66,676,000 -72,061,000 -61,868,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -66,676,000 -72,061,000 -61,868,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -66,676,000 -72,061,000 -61,868,000 UNPUB
Operating Expenses 81,183,000 83,610,000 81,486,000 UNPUB
Operating Income/Loss -66,157,000 -73,108,000 -64,960,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 19,138,000 19,977,000 28,914,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Assets 1,025,368,000 953,444,000 883,793,000 833,268,000
Current Assets 446,877,000 465,424,000 436,639,000 415,976,000
Current Liabilities 119,937,000 114,556,000 123,548,000 130,434,000
Equity 689,669,000 630,519,000 563,824,000 516,195,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 689,669,000 630,519,000 563,824,000 516,195,000
Liabilities 335,699,000 322,925,000 319,969,000 317,073,000
Liabilities And Equity 1,025,368,000 953,444,000 883,793,000 833,268,000
Noncurrent Assets 578,491,000 488,020,000 447,154,000 417,292,000
Noncurrent Liabilities 0 0 196,421,000 186,639,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -153,336,000 -70,499,000 -2,830,000 -248,257,000
Net Cash Flow, Continuing -153,336,000 -70,499,000 -2,830,000 -248,257,000
Net Cash Flow From Financing Activities -6,834,000 -7,669,000 -5,417,000 -28,840,000
Net Cash Flow From Financing Activities, Continuing -6,834,000 -7,669,000 -5,417,000 -28,840,000
Net Cash Flow From Investing Activities -90,591,000 -1,081,000 53,043,000 -11,929,000
Net Cash Flow From Investing Activities, Continuing -90,591,000 -1,081,000 53,043,000 -11,929,000
Net Cash Flow From Operating Activities -55,911,000 -61,749,000 -50,456,000 -207,488,000
Net Cash Flow From Operating Activities, Continuing -55,911,000 -61,749,000 -50,456,000 -207,488,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Comprehensive Income/Loss -86,104,000 -70,992,000 -78,977,000 -293,153,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -86,104,000 -70,992,000 -78,977,000 -293,153,000
Other Comprehensive Income/Loss -9,381,000 -2,813,000 -3,493,000 -12,832,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-04 2022-08-03 2022-11-03 2023-02-28
Basic Earnings Per Share -2 -2 -2 -7
Benefits Costs and Expenses 98,982,000 100,828,000 101,996,000 393,129,000
Cost Of Revenue 15,717,000 12,951,000 13,094,000 54,545,000
Costs And Expenses 93,745,000 95,182,000 97,557,000 375,600,000
Diluted Earnings Per Share -2 -2 -2 -7
Gross Profit 6,501,000 19,698,000 13,418,000 58,179,000
Income/Loss From Continuing Operations After Tax -76,723,000 -68,179,000 -75,484,000 -280,321,000
Income/Loss From Continuing Operations Before Tax -76,764,000 -68,179,000 -75,484,000 -280,405,000
Income Tax Expense/Benefit -41,000 0 0 -84,000
Interest Expense, Operating 6,130,000 6,860,000 5,954,000 23,254,000
Net Income/Loss -76,723,000 -68,179,000 -75,484,000 -280,321,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -76,723,000 -68,179,000 -75,484,000 -280,321,000
Net Income/Loss Available To Common Stockholders, Basic -76,723,000 -68,179,000 -75,484,000 -280,321,000
Operating Expenses 78,028,000 82,231,000 84,463,000 321,055,000
Operating Income/Loss -71,527,000 -62,533,000 -71,045,000 -262,876,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 22,218,000 32,649,000 26,512,000 112,724,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-09 2021-11-02 2022-03-01
Assets 879,442,000 836,402,000 800,395,000 1,113,904,000
Current Assets 498,638,000 437,387,000 410,164,000 518,826,000
Current Liabilities 83,961,000 91,554,000 106,771,000 130,472,000
Equity 554,504,000 507,245,000 461,414,000 764,298,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 554,504,000 507,245,000 461,414,000 764,298,000
Liabilities 324,938,000 329,157,000 338,981,000 349,606,000
Liabilities And Equity 879,442,000 836,402,000 800,395,000 1,113,904,000
Noncurrent Assets 380,804,000 399,015,000 390,231,000 595,078,000
Noncurrent Liabilities 0 0 232,210,000 219,134,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-09 2021-11-02 2022-03-01
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -46,944,000 -34,410,000 -28,685,000 7,483,000
Net Cash Flow, Continuing -46,944,000 -34,410,000 -28,685,000 7,483,000
Net Cash Flow From Financing Activities 208,370,000 -12,337,000 -8,427,000 195,250,000
Net Cash Flow From Financing Activities, Continuing 208,370,000 -12,337,000 -8,427,000 195,250,000
Net Cash Flow From Investing Activities -214,183,000 7,799,000 16,101,000 -406,642,000
Net Cash Flow From Investing Activities, Continuing -214,183,000 7,799,000 16,101,000 -406,642,000
Net Cash Flow From Operating Activities -41,131,000 -29,872,000 -36,359,000 218,875,000
Net Cash Flow From Operating Activities, Continuing -41,131,000 -29,872,000 -36,359,000 218,875,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-09 2021-11-02 2022-03-01
Comprehensive Income/Loss -51,147,000 -57,526,000 -58,435,000 125,631,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -51,147,000 -57,526,000 -58,435,000 125,631,000
Other Comprehensive Income/Loss -1,008,000 113,000 -30,000 -2,209,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-05 2021-08-09 2021-11-02 2022-03-01
Basic Earnings Per Share UNPUB UNPUB -1 3
Benefits Costs and Expenses 69,019,000 79,674,000 89,178,000 329,100,000
Cost Of Revenue 4,851,000 9,819,000 14,105,000 51,833,000
Costs And Expenses 62,926,000 74,261,000 88,121,000 310,367,000
Diluted Earnings Per Share UNPUB UNPUB -1 3
Gross Profit 14,033,000 12,216,000 16,668,000 418,514,000
Income/Loss From Continuing Operations After Tax -50,139,000 -57,639,000 -58,405,000 127,840,000
Income/Loss From Continuing Operations Before Tax -50,135,000 -57,639,000 -58,405,000 141,247,000
Income Tax Expense/Benefit 4,000 0 0 13,407,000
Interest Expense, Operating 6,702,000 6,366,000 6,709,000 26,277,000
Net Income/Loss -50,139,000 -57,639,000 -58,405,000 127,840,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -50,139,000 -57,639,000 -58,405,000 127,840,000
Net Income/Loss Available To Common Stockholders, Basic -50,139,000 -57,639,000 -58,405,000 127,840,000
Operating Expenses 58,075,000 64,442,000 74,016,000 258,534,000
Operating Income/Loss -44,042,000 -52,226,000 -57,348,000 159,980,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 18,884,000 22,035,000 30,773,000 470,347,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-04 2021-03-01
Assets 463,936,000 449,738,000 541,174,000 708,164,000
Current Assets 338,233,000 329,082,000 386,950,000 531,197,000
Current Liabilities 31,789,000 40,203,000 63,613,000 81,447,000
Equity 420,152,000 397,861,000 415,660,000 377,753,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 420,152,000 397,861,000 415,660,000 377,753,000
Liabilities 43,784,000 51,877,000 125,514,000 330,411,000
Liabilities And Equity 463,936,000 449,738,000 541,174,000 708,164,000
Noncurrent Assets 125,703,000 120,656,000 154,224,000 176,967,000
Noncurrent Liabilities 0 0 61,901,000 248,964,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-04 2021-03-01
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -103,000 24,811,000 -1,002,000 268,912,000
Net Cash Flow, Continuing -103,000 24,811,000 -1,002,000 268,912,000
Net Cash Flow From Financing Activities 2,761,000 1,825,000 1,460,000 200,214,000
Net Cash Flow From Financing Activities, Continuing 2,761,000 1,825,000 1,460,000 200,214,000
Net Cash Flow From Investing Activities 32,709,000 44,482,000 33,998,000 122,759,000
Net Cash Flow From Investing Activities, Continuing 32,709,000 44,482,000 33,998,000 122,759,000
Net Cash Flow From Operating Activities -35,573,000 -21,496,000 -36,460,000 -54,061,000
Net Cash Flow From Operating Activities, Continuing -35,573,000 -21,496,000 -36,460,000 -54,061,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-04 2021-03-01
Comprehensive Income/Loss -40,038,000 -33,762,000 8,791,000 -111,815,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -40,823,000 -32,432,000 8,304,000 -111,815,000
Other Comprehensive Income/Loss -785,000 1,330,000 -487,000 -565,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-06 2020-11-04 2021-03-01
Basic Earnings Per Share -1 -1 0 -3
Benefits Costs and Expenses 55,344,000 58,399,000 84,961,000 260,577,000
Cost Of Revenue 3,409,000 4,684,000 17,364,000 35,714,000
Costs And Expenses 55,344,000 58,399,000 84,961,000 273,800,000
Diluted Earnings Per Share -1 -1 0 -3
Gross Profit 14,235,000 11,882,000 81,548,000 118,853,000
Income/Loss From Continuing Operations After Tax -40,038,000 -33,762,000 8,791,000 -111,250,000
Income/Loss From Continuing Operations Before Tax -40,038,000 -34,262,000 8,788,000 -106,010,000
Income Tax Expense/Benefit 0 -500,000 -3,000 5,240,000
Interest Expense, Operating UNPUB UNPUB UNPUB 771,000
Net Income/Loss -40,038,000 -33,762,000 8,791,000 -111,250,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -40,038,000 -33,762,000 8,791,000 -111,250,000
Net Income/Loss Available To Common Stockholders, Basic -40,038,000 -33,762,000 8,791,000 -111,250,000
Operating Expenses 55,344,000 58,399,000 84,961,000 238,086,000
Operating Income/Loss -37,700,000 -41,833,000 13,951,000 -119,233,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 17,644,000 16,566,000 98,912,000 154,567,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-07 2019-11-05 2020-02-26
Assets 519,031,000 529,139,000 509,237,000 497,908,000
Current Assets 303,884,000 359,492,000 360,228,000 345,032,000
Current Liabilities 21,390,000 24,661,000 31,345,000 33,676,000
Equity 487,053,000 494,592,000 468,395,000 450,197,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 487,053,000 494,592,000 468,395,000 450,197,000
Liabilities 31,978,000 34,547,000 40,842,000 47,711,000
Liabilities And Equity 519,031,000 529,139,000 509,237,000 497,908,000
Noncurrent Assets 215,147,000 169,647,000 149,009,000 152,876,000
Noncurrent Liabilities 0 0 9,497,000 14,035,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-07 2019-11-05 2020-02-26
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -19,709,000 -710,000 24,452,000 -5,770,000
Net Cash Flow, Continuing -19,709,000 -710,000 24,452,000 -5,770,000
Net Cash Flow From Financing Activities 4,127,000 1,367,000 1,333,000 8,376,000
Net Cash Flow From Financing Activities, Continuing 4,127,000 1,367,000 1,333,000 8,376,000
Net Cash Flow From Investing Activities 5,461,000 21,672,000 52,272,000 93,559,000
Net Cash Flow From Investing Activities, Continuing 5,461,000 21,672,000 52,272,000 93,559,000
Net Cash Flow From Operating Activities -29,297,000 -23,749,000 -29,153,000 -107,705,000
Net Cash Flow From Operating Activities, Continuing -29,297,000 -23,749,000 -29,153,000 -107,705,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-07 2019-11-05 2020-02-26
Comprehensive Income/Loss -32,228,000 -1,457,000 -34,584,000 -93,848,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -31,607,000 -927,000 -34,692,000 -93,848,000
Other Comprehensive Income/Loss 621,000 530,000 -108,000 885,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-07 2019-08-07 2019-11-05 2020-02-26
Basic Earnings Per Share -1 0 -1 -3
Benefits Costs and Expenses 36,790,000 44,753,000 50,596,000 132,721,000
Cost Of Revenue 29,000 1,927,000 2,494,000 8,241,000
Costs And Expenses 36,790,000 44,753,000 50,596,000 184,231,000
Diluted Earnings Per Share -1 0 -1 -3
Gross Profit 855,000 5,954,000 12,206,000 26,992,000
Income/Loss From Continuing Operations After Tax -32,228,000 -1,457,000 -34,584,000 -94,733,000
Income/Loss From Continuing Operations Before Tax -32,298,000 -1,586,000 -34,749,000 -97,488,000
Income Tax Expense/Benefit -70,000 -129,000 -165,000 -2,755,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -32,228,000 -1,457,000 -34,584,000 -94,733,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -32,228,000 -1,457,000 -34,584,000 -94,733,000
Net Income/Loss Available To Common Stockholders, Basic -32,228,000 -1,457,000 -34,584,000 -94,733,000
Operating Expenses 36,790,000 44,753,000 50,596,000 175,990,000
Operating Income/Loss -35,906,000 -36,872,000 -35,896,000 -148,998,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 884,000 7,881,000 14,700,000 35,233,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-08 2018-11-07 2019-02-27
Assets 317,217,000 335,987,000 514,984,000 543,814,000
Current Assets 262,718,000 293,270,000 386,357,000 337,913,000
Current Liabilities 14,876,000 16,853,000 19,120,000 22,176,000
Equity 299,340,000 317,222,000 494,057,000 508,848,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 299,340,000 317,222,000 494,057,000 508,848,000
Liabilities 17,877,000 18,765,000 20,927,000 34,966,000
Liabilities And Equity 317,217,000 335,987,000 514,984,000 543,814,000
Noncurrent Assets 54,499,000 42,717,000 128,627,000 205,901,000
Noncurrent Liabilities 3,001,000 1,912,000 1,807,000 12,790,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-08 2018-11-07 2019-02-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 25,214,000 35,019,000 35,534,000 29,733,000
Net Cash Flow, Continuing 25,214,000 35,019,000 35,534,000 29,733,000
Net Cash Flow From Financing Activities 4,166,000 3,175,000 191,814,000 204,443,000
Net Cash Flow From Financing Activities, Continuing 4,166,000 3,175,000 191,814,000 204,443,000
Net Cash Flow From Investing Activities -37,086,000 -38,367,000 -136,723,000 -279,358,000
Net Cash Flow From Investing Activities, Continuing -37,086,000 -38,367,000 -136,723,000 -279,358,000
Net Cash Flow From Operating Activities 58,134,000 70,211,000 -19,557,000 104,648,000
Net Cash Flow From Operating Activities, Continuing 58,134,000 70,211,000 -19,557,000 104,648,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-08 2018-11-07 2019-02-27
Comprehensive Income/Loss 104,239,000 10,594,000 -19,202,000 99,932,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 104,051,000 10,726,000 -19,305,000 99,932,000
Other Comprehensive Income/Loss -188,000 132,000 -103,000 -5,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-08 2018-08-08 2018-11-07 2019-02-27
Basic Earnings Per Share 3 0 -1 3
Benefits Costs and Expenses 30,366,000 33,681,000 28,031,000 114,389,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 30,366,000 33,681,000 28,031,000 130,405,000
Diluted Earnings Per Share 3 0 -1 3
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax 104,239,000 10,594,000 -19,202,000 99,937,000
Income/Loss From Continuing Operations Before Tax 102,025,000 14,444,000 -20,494,000 104,116,000
Income Tax Expense/Benefit 0 3,850,000 -1,292,000 4,179,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 104,239,000 10,594,000 -19,202,000 99,937,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 104,239,000 10,594,000 -19,202,000 99,937,000
Net Income/Loss Available To Common Stockholders, Basic 104,239,000 10,594,000 -19,202,000 99,937,000
Operating Expenses 30,366,000 33,681,000 28,031,000 130,405,000
Operating Income/Loss 102,025,000 6,350,000 -22,725,000 88,100,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 132,391,000 40,031,000 5,306,000 218,505,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-09 2017-08-08 2017-11-08 2018-03-06
Assets 224,127,000 224,376,000 209,255,000 198,677,000
Current Assets 148,802,000 165,817,000 172,161,000 167,997,000
Current Liabilities 9,958,000 11,462,000 13,399,000 14,437,000
Equity 212,898,000 211,697,000 194,651,000 183,029,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 212,898,000 211,697,000 194,651,000 183,029,000
Liabilities 11,229,000 12,679,000 14,604,000 15,648,000
Liabilities And Equity 224,127,000 224,376,000 209,255,000 198,677,000
Noncurrent Assets 75,325,000 58,559,000 37,094,000 30,680,000
Noncurrent Liabilities 1,271,000 1,217,000 1,205,000 1,211,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-09 2017-08-08 2017-11-08 2018-03-06
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 57,205,000 -24,396,000 2,235,000 21,816,000
Net Cash Flow, Continuing 57,205,000 -24,396,000 2,235,000 21,816,000
Net Cash Flow From Financing Activities 71,523,000 10,728,000 606,000 84,598,000
Net Cash Flow From Financing Activities, Continuing 71,523,000 10,728,000 606,000 84,598,000
Net Cash Flow From Investing Activities 3,163,000 -25,575,000 18,765,000 -4,790,000
Net Cash Flow From Investing Activities, Continuing 3,163,000 -25,575,000 18,765,000 -4,790,000
Net Cash Flow From Operating Activities -17,481,000 -9,549,000 -17,136,000 -57,992,000
Net Cash Flow From Operating Activities, Continuing -17,481,000 -9,549,000 -17,136,000 -57,992,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-09 2017-08-08 2017-11-08 2018-03-06
Comprehensive Income/Loss -21,993,000 -14,473,000 -20,706,000 -73,851,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -22,532,000 -14,547,000 -20,613,000 -73,851,000
Other Comprehensive Income/Loss -539,000 -74,000 93,000 -682,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-09 2017-08-08 2017-11-08 2018-03-06
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 23,377,000 21,618,000 22,645,000 83,562,000
Cost Of Revenue 0 6,000 0 6,000
Costs And Expenses 23,377,000 21,618,000 22,645,000 86,278,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 455,000 6,556,000 1,336,000 10,387,000
Income/Loss From Continuing Operations After Tax -21,993,000 -14,473,000 -20,706,000 -73,169,000
Income/Loss From Continuing Operations Before Tax -22,922,000 -15,056,000 -21,309,000 -73,169,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -21,993,000 -14,473,000 -20,706,000 -73,169,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,993,000 -14,473,000 -20,706,000 -73,169,000
Net Income/Loss Available To Common Stockholders, Basic -21,993,000 -14,473,000 -20,706,000 -73,169,000
Operating Expenses 23,377,000 21,618,000 22,645,000 86,272,000
Operating Income/Loss -22,922,000 -15,056,000 -21,309,000 -75,885,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 455,000 6,562,000 1,336,000 10,393,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-09 2016-11-09 2017-03-07
Assets 214,984,000 206,072,000 195,975,000 172,732,000
Current Assets 105,580,000 97,907,000 96,620,000 93,371,000
Current Liabilities 5,781,000 9,149,000 14,382,000 9,669,000
Equity 208,601,000 196,175,000 180,226,000 161,737,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 208,601,000 196,175,000 180,226,000 161,737,000
Liabilities 6,383,000 9,897,000 15,749,000 10,995,000
Liabilities And Equity 214,984,000 206,072,000 195,975,000 172,732,000
Noncurrent Assets 109,404,000 108,165,000 99,355,000 79,361,000
Noncurrent Liabilities 602,000 748,000 1,367,000 1,326,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-09 2016-11-09 2017-03-07
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -18,605,000 -5,428,000 -1,975,000 -29,276,000
Net Cash Flow, Continuing -18,605,000 -5,428,000 -1,975,000 -29,276,000
Net Cash Flow From Financing Activities 21,000 109,000 44,000 119,000
Net Cash Flow From Financing Activities, Continuing 21,000 109,000 44,000 119,000
Net Cash Flow From Investing Activities -10,739,000 2,893,000 9,799,000 19,163,000
Net Cash Flow From Investing Activities, Continuing -10,739,000 2,893,000 9,799,000 19,163,000
Net Cash Flow From Operating Activities -7,887,000 -8,430,000 -11,818,000 -48,558,000
Net Cash Flow From Operating Activities, Continuing -7,887,000 -8,430,000 -11,818,000 -48,558,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-09 2016-11-09 2017-03-07
Comprehensive Income/Loss -10,768,000 -14,437,000 -18,154,000 -62,281,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -9,774,000 -14,191,000 -17,822,000 -62,281,000
Other Comprehensive Income/Loss 994,000 246,000 332,000 686,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-09 2016-11-09 2017-03-07
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 11,644,000 17,327,000 18,793,000 67,991,000
Cost Of Revenue 30,000 49,000 22,000 98,000
Costs And Expenses 11,644,000 17,327,000 18,793,000 69,929,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 363,000 2,326,000 103,000 4,491,000
Income/Loss From Continuing Operations After Tax -10,768,000 -14,437,000 -18,154,000 -62,967,000
Income/Loss From Continuing Operations Before Tax -11,251,000 -14,952,000 -18,668,000 -63,402,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -435,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -10,768,000 -14,437,000 -18,154,000 -62,967,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -10,768,000 -14,437,000 -18,154,000 -62,967,000
Net Income/Loss Available To Common Stockholders, Basic -10,768,000 -14,437,000 -18,154,000 -62,967,000
Operating Expenses 11,644,000 17,327,000 18,793,000 69,831,000
Operating Income/Loss -11,251,000 -14,952,000 -18,668,000 -65,340,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 393,000 2,375,000 125,000 4,589,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2015-11-05 2016-03-03
Assets UNPUB UNPUB 227,314,000 221,380,000
Current Assets UNPUB UNPUB 215,485,000 118,148,000
Current Liabilities UNPUB UNPUB 5,308,000 4,339,000
Equity UNPUB UNPUB 221,808,000 216,808,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 221,808,000 216,808,000
Liabilities UNPUB UNPUB 5,506,000 4,572,000
Liabilities And Equity UNPUB UNPUB 227,314,000 221,380,000
Noncurrent Assets UNPUB UNPUB 11,829,000 103,232,000
Noncurrent Liabilities UNPUB UNPUB 198,000 233,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2015-11-05 2016-03-03
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB 52,995,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 52,995,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 239,310,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 239,310,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -163,800,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -163,800,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -22,515,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -22,515,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2015-11-05 2016-03-03
Comprehensive Income/Loss UNPUB UNPUB -7,332,000 -23,530,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -7,358,000 -23,530,000
Other Comprehensive Income/Loss UNPUB UNPUB -26,000 -719,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2015-11-05 2016-03-03
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB 8,487,000 30,725,000
Cost Of Revenue UNPUB UNPUB 44,000 98,000
Costs And Expenses UNPUB UNPUB 8,487,000 30,725,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB 1,096,000 7,490,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB -7,332,000 -22,811,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB -7,347,000 -23,137,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB 20,000
Net Income/Loss UNPUB UNPUB -7,332,000 -22,811,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB -7,332,000 -22,811,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -7,332,000 -23,799,000
Operating Expenses UNPUB UNPUB 8,487,000 30,627,000
Operating Income/Loss UNPUB UNPUB -7,347,000 -23,137,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 0 1,747,000
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 0 1,747,000
Revenues UNPUB UNPUB 1,140,000 7,588,000
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
★★
11:30
United States
★
11:30
United States
5.275
★
11:30
United States
5.270
★
11:30
United States
★
11:30
United States
★★
10:30
United States
★
10:30
United States
MAY 10
79000000000.000
76000000000.000
★
10:30
United States
MAY 10
★★
10:00
United States
★
09:15
United States
APR
-0.300
0.200
0.100
★★
09:15
United States
APR
-0.380
0.090
★
09:15
United States
APR
78.400
78.500
78.400
★
09:15
United States
APR
★★
08:30
United States
APR
0.500
0.100
0.400
★★
08:30
United States
APR
1440000.000
1458000.000
1480000.000
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:RGNX240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:RGNX240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:RGNX240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:RGNX240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:RGNX240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:RGNX240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:RGNX240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:RGNX240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:RGNX240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:RGNX240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:RGNX240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:RGNX240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:RGNX240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:RGNX240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:RGNX240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:RGNX240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:RGNX240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:RGNX240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:RGNX240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:RGNX240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:RGNX240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:RGNX240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:RGNX240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:RGNX240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:RGNX240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:RGNX240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:RGNX240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:RGNX240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:RGNX240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:RGNX240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:RGNX240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:RGNX240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:RGNX240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:RGNX240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:RGNX240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:RGNX240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:RGNX240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:RGNX240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:RGNX240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:RGNX240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:RGNX240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:RGNX240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:RGNX240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:RGNX240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:RGNX240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:RGNX240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:RGNX240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:RGNX240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:RGNX240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:RGNX240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:RGNX240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:RGNX240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:RGNX240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:RGNX240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:RGNX240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:RGNX240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:RGNX240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:RGNX240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:RGNX240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:RGNX240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:RGNX240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:RGNX240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:RGNX240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:RGNX240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:RGNX240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:RGNX240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:RGNX240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:RGNX240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:RGNX240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:RGNX240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:RGNX240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:RGNX240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:RGNX240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:RGNX240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:RGNX240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:RGNX240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:RGNX240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:RGNX240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:RGNX240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:RGNX240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:RGNX240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:RGNX240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:RGNX240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:RGNX240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:RGNX240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:RGNX240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:RGNX240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:RGNX240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:RGNX240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:RGNX240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:RGNX240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:RGNX240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:RGNX240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:RGNX240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:RGNX240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:RGNX240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:RGNX240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:RGNX240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:RGNX240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:RGNX240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:RGNX240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:RGNX240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:RGNX240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:RGNX240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:RGNX240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:RGNX240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:RGNX240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:RGNX240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:RGNX231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:RGNX231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:RGNX231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:RGNX231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:RGNX231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:RGNX231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:RGNX231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:RGNX231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:RGNX231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:RGNX231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:RGNX231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:RGNX231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:RGNX231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:RGNX231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:RGNX231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:RGNX231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:RGNX231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:RGNX231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:RGNX231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:RGNX231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:RGNX231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:RGNX231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:RGNX231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:RGNX231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:RGNX231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:RGNX231117P00022500 OPASPS Put American 100 22.5 BATO 2023-11-17
O:RGNX231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:RGNX231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:RGNX231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:RGNX231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:RGNX231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:RGNX231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:RGNX231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:RGNX231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:RGNX231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:RGNX231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:RGNX231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:RGNX231117C00022500 OCASPS Call American 100 22.5 BATO 2023-11-17
O:RGNX231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:RGNX231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:RGNX231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:RGNX231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:RGNX231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:RGNX231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:RGNX231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:RGNX231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:RGNX231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:RGNX231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:RGNX231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:RGNX231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:RGNX231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:RGNX231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:RGNX231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:RGNX231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:RGNX231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:RGNX231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:RGNX231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:RGNX231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:RGNX231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:RGNX231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:RGNX231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:RGNX231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:RGNX231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:RGNX231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:RGNX231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:RGNX231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:RGNX231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:RGNX231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:RGNX231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:RGNX231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:RGNX230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:RGNX230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:RGNX230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:RGNX230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:RGNX230915P00020000 OPASPS Put American 100 20 BATO 2023-09-15
O:RGNX230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:RGNX230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:RGNX230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:RGNX230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:RGNX230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:RGNX230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:RGNX230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:RGNX230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:RGNX230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:RGNX230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:RGNX230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:RGNX230915C00020000 OCASPS Call American 100 20 BATO 2023-09-15
O:RGNX230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:RGNX230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:RGNX230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:RGNX230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:RGNX230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:RGNX230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:RGNX230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:RGNX230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:RGNX230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:RGNX230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:RGNX230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:RGNX230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:RGNX230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:RGNX230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:RGNX230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:RGNX230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:RGNX230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:RGNX230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:RGNX230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:RGNX230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:RGNX230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:RGNX230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:RGNX230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:RGNX230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:RGNX230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:RGNX230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:RGNX230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:RGNX230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:RGNX230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:RGNX230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
O:RGNX230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
News Stream
Analyst Analyst Ratings
Where Regenxbio Stands With Analysts
Analysts' ratings for Regenxbio (NASDAQ:RGNX) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 4 2 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 4 2 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $38.22, a high estimate of $55.00, and a low estimate of $21.00. This current average has increased by 1.25% from the previous average price target of $37.75. Deciphering Analyst Ratings: An In-Depth Analysis In examining recent analyst actions, we gain insights into how financial experts perceive Regenxbio. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Annabel Samimy Stifel Maintains Buy $40.00 - Yi Chen HC Wainwright & Co. Announces Buy $36.00 - Luca Issi RBC Capital Raises Outperform $35.00 $20.00 Daniil Gataulin Chardan Capital Maintains Buy $52.00 $52.00 Gena Wang Barclays Raises Overweight $55.00 $45.00 Brian Skorney Baird Raises Outperform $39.00 $34.00 Andreas Argyrides Wedbush Maintains Neutral $21.00 - Dane Leone Raymond James Announces Outperform $45.00 - Andreas Argyrides Wedbush Maintains Neutral $21.00 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects ...Full story available on Benzinga.com
Benzinga • 1mo ago
Analyst Analyst Ratings
Beyond The Numbers: 4 Analysts Discuss Regenxbio Stock
4 analysts have expressed a variety of opinions on Regenxbio (NASDAQ:RGNX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 2 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $31.5, along with a high estimate of $45.00 and a low estimate of $21.00. A 7.35% drop is evident in the current average compared to the previous average price target of $34.00. Breaking Down Analyst Ratings: A Detailed Examination In examining recent analyst actions, we gain insights into how financial experts perceive Regenxbio. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Brian Skorney Baird Raises Outperform $39.00 $34.00 Andreas Argyrides Wedbush Maintains Neutral $21.00 - Dane Leone Raymond James Announces Outperform $45.00 - Andreas Argyrides Wedbush Maintains Neutral $21.00 - Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Regenxbio. ...Full story available on Benzinga.com
Benzinga • 2mo ago
News News
Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -12.60% and 19.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 2mo ago
News News
Strength Seen in Regenxbio (RGNX): Can Its 11.7% Jump Turn into More Strength?
Regenxbio (RGNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks Investment Research • 3mo ago
News News
Down -25.53% in 4 Weeks, Here's Why You Should You Buy the Dip in Regenxbio (RGNX)
Regenxbio (RGNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks Investment Research • 4mo ago
News News
Wall Street Analysts Believe Regenxbio (RGNX) Could Rally 95.61%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 95.6% in Regenxbio (RGNX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Investment Research • 6mo ago
Analyst Analyst Ratings
What 4 Analyst Ratings Have To Say About Regenxbio
Over the past 3 months, 4 analysts have published their opinion on Regenxbio (NASDAQ:RGNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 1 0 1 0 0 These 4 analysts have an average price target of $34.25 versus the current price of Regenxbio at $16.86, implying upside. Below is a summary of how these 4 analysts rated Regenxbio over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock ...Full story available on Benzinga.com
Benzinga • 7mo ago
Analyst Analyst Ratings
The Latest Analyst Ratings for Regenxbio
Over the past 3 months, 5 analysts have published their opinion on Regenxbio (NASDAQ:RGNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 1 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 0 2 0 0 0 These 5 analysts have an average price target of $40.2 versus the current price of Regenxbio at $18.95, implying upside. Below is a summary of how these 5 analysts rated Regenxbio over the past 3 months. The greater the number of bullish ratings, ...Full story available on Benzinga.com
Benzinga • 8mo ago
News News
Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -31.75% and 49.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 9mo ago
News News
Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -31.75% and 49.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 9mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT